<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>12</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">E. I. O. Ajayi</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">How ‘diabetes egg-box’ can save some HIV-patients from additional disease?</style></title><secondary-title><style face="normal" font="default" size="100%">Sparrho Newsletter</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2018</style></year></dates><urls><web-urls><url><style face="normal" font="default" size="100%">https://www.sparrho.com/pinboard/how-diabetes-egg-box-can-save-some-hiv-patients-from-additional-disease/232857/</style></url></web-urls></urls><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;&lt;span data-mce-mark=&quot;1&quot;&gt;Antiretroviral drugs have greatly extended the life span of HIV-infected persons, but research suggests they are in high risk of developing diabetes (Nduka et al., 2017). A new tool to preserve vital cells for diabetes treatment can help people with both conditions.&amp;nbsp;&lt;span data-mce-mark=&quot;1&quot;&gt;Scientists can now save most pre-transplant ‘islet cells’ derived from donors that are vital to restore insulin production in Type 1 diabetes patients. This is important news for HIV positive people, who are on antiretroviral&amp;nbsp; therapy (ART).&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;Keywords: HIV, antiretroviral therapy, diabetes&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue></record></records></xml>